Anand J, Droby G, Joseph S, Patel U, Zhang X, Klomp J
bioRxiv. 2025; .
PMID: 39975297
PMC: 11838190.
DOI: 10.1101/2025.01.26.634889.
Li Y, Wang W, Sun L, Huang J, Ma X, Li S
J Mol Histol. 2024; 56(1):54.
PMID: 39722070
DOI: 10.1007/s10735-024-10323-0.
Li S, Li J, Zhou H, Xiong L
Ibrain. 2023; 7(1):57-67.
PMID: 37786870
PMC: 10528794.
DOI: 10.1002/j.2769-2795.2021.tb00066.x.
Werner H, LeRoith D
Front Oncol. 2022; 12:1055589.
PMID: 36479090
PMC: 9720135.
DOI: 10.3389/fonc.2022.1055589.
Piao M, Feng G
Int Wound J. 2022; 20(5):1517-1524.
PMID: 36333840
PMC: 10088848.
DOI: 10.1111/iwj.14006.
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.
Martins F, Couturier D, de Santiago I, Sauer C, Vias M, Angelova M
Nat Commun. 2022; 13(1):6360.
PMID: 36289203
PMC: 9606297.
DOI: 10.1038/s41467-022-33870-0.
Selective targeting of MYC mRNA by stabilized antisense oligonucleotides.
Gill T, Wang H, Bandaru R, Lawlor M, Lu C, Nieman L
Oncogene. 2021; 40(47):6527-6539.
PMID: 34650218
PMC: 8627489.
DOI: 10.1038/s41388-021-02053-4.
Role of PDGF-A/B Ligands in Cardiac Repair After Myocardial Infarction.
Kalra K, Eberhard J, Farbehi N, Chong J, Xaymardan M
Front Cell Dev Biol. 2021; 9:669188.
PMID: 34513823
PMC: 8424099.
DOI: 10.3389/fcell.2021.669188.
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Ahmadi S, Rahimi S, Zarandi B, Chegeni R, Safa M
J Hematol Oncol. 2021; 14(1):121.
PMID: 34372899
PMC: 8351444.
DOI: 10.1186/s13045-021-01111-4.
Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment.
Bao X, Liu X, Li F, Li C
Cell Biosci. 2020; 10:81.
PMID: 32566127
PMC: 7302000.
DOI: 10.1186/s13578-020-00442-y.
Lupenone Protects Neuroblastoma SH-SY5y Cells Against Methamphetamine-Induced Apoptotic Cell Death via PI3K/Akt/mTOR Signaling Pathway.
Lee H, Kim E, Jeong G
Int J Mol Sci. 2020; 21(5).
PMID: 32120831
PMC: 7084488.
DOI: 10.3390/ijms21051617.
Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells.
Yu N, Chen P, Wang Q, Liang M, Qiu J, Zhou P
Oncol Lett. 2020; 19(1):460-468.
PMID: 31897159
PMC: 6923973.
DOI: 10.3892/ol.2019.11111.
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.
Kreuzaler P, Clarke M, Brown E, Wilson C, Kortlever R, Piterman N
Proc Natl Acad Sci U S A. 2019; 116(44):22399-22408.
PMID: 31611367
PMC: 6825310.
DOI: 10.1073/pnas.1903485116.
The Platelet Response to Tissue Injury.
Eisinger F, Patzelt J, Langer H
Front Med (Lausanne). 2018; 5:317.
PMID: 30483508
PMC: 6242949.
DOI: 10.3389/fmed.2018.00317.
Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
Ciribilli Y, Borlak J
Oncotarget. 2017; 8(60):101808-101831.
PMID: 29254206
PMC: 5731916.
DOI: 10.18632/oncotarget.21981.
Inferring gene and protein interactions using PubMed citations and consensus Bayesian networks.
Deeter A, Dalman M, Haddad J, Duan Z
PLoS One. 2017; 12(10):e0186004.
PMID: 29049295
PMC: 5648141.
DOI: 10.1371/journal.pone.0186004.
Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis.
Cartwright I, Liu X, Zhou M, Li F, Li C
Elife. 2017; 6.
PMID: 28691902
PMC: 5550274.
DOI: 10.7554/eLife.26371.
Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals.
Tian X, Huang B, Zhang X, Lu M, Liu F, Onuchic J
Proc Natl Acad Sci U S A. 2017; 114(21):5337-5342.
PMID: 28484034
PMC: 5448174.
DOI: 10.1073/pnas.1702412114.
Molecular chess? Hallmarks of anti-cancer drug resistance.
Cree I, Charlton P
BMC Cancer. 2017; 17(1):10.
PMID: 28056859
PMC: 5214767.
DOI: 10.1186/s12885-016-2999-1.
Akt isoforms in vascular disease.
Yu H, Littlewood T, Bennett M
Vascul Pharmacol. 2015; 71:57-64.
PMID: 25929188
PMC: 4728195.
DOI: 10.1016/j.vph.2015.03.003.